Analysis of variation of serum CEA, SCC, CYFRA21-1 in patients with lung cancer and their diagnostic value with EBUS-TBNA

To explore the variation of serum carcinoembryonic antigen (CEA), cytokeratin 19 fragment (CYFRA21-1), and squamous cell carcinoma (SCC) antigen in patients with lung cancer (LC) and their diagnostic value with endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). This study...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical biochemistry 2024-06, Vol.43 (4), p.363-371
Hauptverfasser:	Du, Yanjia, Wen, Ya, Huang, Jieyu
Format:	Artikel
Sprache:	eng
Schlagworte:	carcinoembryonic antigen cytokeratin 19 fragment diagnostic value joint diagnosis lung cancer Original Paper pathological type squamous cell carcinoma antigen ultrasound-guided transbronchial needle aspiration
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To explore the variation of serum carcinoembryonic antigen (CEA), cytokeratin 19 fragment (CYFRA21-1), and squamous cell carcinoma (SCC) antigen in patients with lung cancer (LC) and their diagnostic value with endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). This study examined the diagnostic value of serum tumor marker testing and EBUS-TBNA joint detection for LC in 150 patients with suspected LC. Compared to benign patients, the serum levels of CYFRA21-1, SCC, and CEA in LC were higher (P
ISSN:	1452-8258 1452-8266
DOI:	10.5937/jomb0-37083